News & Events
Show:
February 6, 2025
Crinetics Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on February 27, 2025
Event Date: February 27, 2025
READ MORE
February 6, 2025
Crinetics to Report Fourth Quarter and Full Year 2024 Financial Results
Event Date: February 27, 2025
READ MORE
January 10, 2025
Crinetics Announces Positive Topline Results From Phase 2 Trial of Atumelnant in Congenital Adrenal Hyperplasia
Event Date: January 10, 2025
READ MORE
January 6, 2025
Crinetics to Participate in the 43rd Annual J.P. Morgan Healthcare Conference
Event Date: January 14, 2025
READ MORE
December 5, 2024
Piper Sandler 36th Annual Healthcare Conference
Event Date: December 5, 2024
READ MORE
November 15, 2024
Crinetics Pharmaceuticals to Participate in Three Upcoming December Investor Conferences
Event Date: December 3, 2024
READ MORE
November 12, 2024
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12
Event Date: November 12, 2024
READ MORE
October 16, 2024
Crinetics Pharmaceuticals to Report Third Quarter 2024 Financial Results on November 12, 2024
Event Date: November 12, 2024
READ MORETransforming Endocrine Disease Treatment
Be the first to know about the advances we're making in endocrine-rooted care.
Email Signup
You are now leaving Crinetics.com
Please click CONTINUE below to learn more about a new treatment option. This website contains information about a prescription medicine.
